Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sandeep Soni, MD
Researcher Executive Director
CRISPR Therapeutics, Inc.
610 Main Street
Cambridge, Massachusetts, United States
Sandeep Soni, MD, is the Executive Director at CRISPR Therapeutics, Inc. His expertise includes bone marrow transplantation (HSCT), cellular therapies and gene therapy for malignant and non-malignant blood disorders and clinical development of programs. He is also an expert of lentiviral vectors, Crispr- Cas9 gene editing, stem cell transplant, T-cell therapies and regulatory/safety aspects of gene-therapies.
Areas of Interest-
– Cellular Therapy
– Gene Therapy
– Stem Cell Transplant
– Sickle Cell Disease
– Thalassemia
– Reduced Intensity Conditioning
Clinical Focus-
– Hematology/Oncology
– Stem Cell Transplant and Gene Therapy
+myBinderRelated Content
-
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trend...The objective of this study was to analy...
-
Why do blood types matter? – Natalie S. Hodgehttps://www.youtube.com/watch?v=xfZhb6lm...
-
Sohail Rana, MDDr. Rana is Professor of Pediatrics at H...
-
Edward Donnell IvyEdward Donnell Ivy is a Director of Outr...
-
University of North Carolina at Chapel Hill School of Medicine, Division of Hematology/OncologyThe Division of Hematology/Oncology offe...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Pediatric to Adult Transition in Sickle Cell Disease: Survey Results From Young Adult PatientsBackground/Aims: We surveyed sickle cel...
